$1.48
-0.18-10.84%
At close: -
$1.47
-0.01-0.68%
After Hours: Jan 17, 7:55 PM EDT
Palisade Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Palisade Bio using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-2.32 | $-3.35 | 30.8 % |
Q2 | 2024-08-12 | $-3.32 | $-2.93 | -13.3 % |
Q1 | 2024-05-13 | $-4.59 | $-4.28 | -7.24 % |
Q4 | 2024-03-26 | $-3.75 | $-5.10 | 26.5 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Palisade Bio (PALI) is scheduled to report earnings on March 25, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-2.32, which beat the estimate of $-3.35.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.